U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

Models suggest societal upheaval from anti-obesity medicines — but impacts are hard to predict.

Robert F. Kennedy Jr. has pledged to tackle high rates of chronic diseases such as diabetes and obesity as President-elect ...

What’s unique about GLP-1s—a.k.a. Ozempic, Monjauro, Wegovy, and Zepbound, among others—is that they target hormones, which ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

The popular weight loss drugs have also been found to reduce other risks, including the risk of death from COVID-19.